Dr. Constantine Alifrangis is a Consultant Medical Oncologist specializing in the treatment of urological cancers, including prostate, bladder, testicular, and penile cancer. He graduated from Guys' Kings and St Thomas' Medical School and was awarded the University Gold Medal for medicine. Following this, he completed his postgraduate medical training in oncology at Imperial College London. Dr. Alifrangis undertook research into advanced prostate cancer at Hammersmith and was awarded a Wellcome fellowship to research the link between cancer genetics and the efficacy of novel therapies. He was awarded a PhD by the University of Cambridge in 2014 for this work. He was also awarded the Sylvia Lawler prize by the Oncology section of the Royal Society of Medicine. Dr. Alifrangis is the Lead Oncologist for Testicular Cancer, treating patients with advanced prostate cancer, and is part of a specialist team looking after patients with penile cancer. His areas of expertise include chemotherapy, bladder cancer, genito-urinary cancer, penile cancer, prostate cancer, and testicular cancer.